Latest News
Group K Diagnostics partners with Health Network Laboratories to begin clinical trial in liver function
21 August 2019 - Biotechnology company Group K Diagnostics (GKD) said on Tuesday that it plans to introduce improved clinical experiences to patients and caregivers alike under a partnership with Health Network Laboratories (HNL), a laboratory medici...
Alligator Bioscience announces antibody agreement with Biotheus Inc for Greater China
21 August 2019 - Biotechnology company Alligator Bioscience (Nasdaq Stockholm:ATORX) announced Tuesday that it has entered into a license agreement for an antibody from ALLIGATOR-GOLD for up to three bispecific molecules with Chinese biotechnology co...
NKMax America announces launch of Phase I clinical trial of SNK in Mexico in patients with psoriasis
21 August 2019 - Biotechnology company NKMax America stated on Tuesday that it has dosed its first patient with plaque psoriasis under its SNK01-MX03 phase I clinical trial of SNK at Angeles Hospital,Tijuana, Mexico.The company said SNK is an ex vivo...
AstraZeneca reports positive results for Farxiga from phase III DAPA-HF trial
21 August 2019 - AstraZeneca Plc (LON:AZN), a global, science-led biopharmaceutical company, reported on Tuesday positive results from the landmark phase III DAPA-HF trial, which showed that Farxiga (dapagliflozin) met the primary composite endpoint ...
Cassiopea submits NDA to US FDA for clascoterone cream 1% acne treatment
21 August 2019 - Pharmaceutical company Cassiopea SpA (SIX:SKIN) said on Tuesday that it has filed a New Drug Application (NDA) with the US Food and Drug Administration (FDA) seeking marketing approval for clascoterone cream 1% for the treatment of t...